LGALS3 and serum lipopolysaccharide activity: On the other hand, Gal3 has been reported to act as a negative regulator of LPS-induced endotoxemia and inflammation, which was explained by the ability of Gal3 to bind to LPS to further inhibit the endotoxin-associated pro-inflammatory response [29].